About us

We are ZeptoSense, We Develop Solutions

OUR MISSION

Nothing can hide beyond the invisible. Pushing the boundaries of the DNA, RNA and protein detection by developing the most sensitive genotyping and sequencing products is the mission of the ZeptoSense.

OUR VISION

We aim to become the leading provider of solutions to specific challenges coming from the up-stream DNA interrogation processes of low copy number DNA, RNA, or proteins.   We are developing the most sensitive and the highest quality products and services for genotyping and sequencing of the DNA, RNA and specific protein samples. Our philosophy is simple, to provide accurate, reliable, easy-to-use genotyping and sequencing products that don’t require additional investments in instrumentation in order to increase the detection/genotyping/sequencing capabilities of the customer’s laboratories.

WHY US

We are developing the most sensitive genotyping and sequencing assays and kits that can be used on current instruments/platforms (Thermo Fisher Scientific, Illumina) so there is no need for additional investments in hardware or software.

News

May 1-4, ZeptoSense’s CFO Pero Dimsoski and Scientific Advisers Stacey Schultz-Cherry and Bratislav Stankovic, were invited to present the research titled “Detection of a single SARS-CoV-2 Viral Copy using zPCR” @ the Clinical Virology Symposium, American Society of Microbiology.

https://asm.org/Events/Clinical-Virology-Symposium/Home

 

 

January-April, 2022. The ZeptoSense team, was invited to participate in the commercialization training program offered by Point Of Care Technology Research Network POCTRN CRAASH, initiative of NIBIB (National Institute of Biomedical Imaging and Bioengineering). Only 8 companies were selected to attend commercialization training program for 2022. For more information regarding the program please visit the following web sites:

https://www.poctrn.org

https://www.cimit.org

Products

ZeptoSense is currently developing ultrasensitive kits for detecting SARS-CoV-2 and other Coronaviruses, Anthrax, human DNA, and low-copy protein detection. We are also planing to develop ultrasensitive sample prep kits for Sanger and NGS sequencing.

Team

Our team of professionals

Pero Dimsoski

Ph.D.; FOUNDER AND CHIEF SCIENTIFIC OFFICER

Dr. Pero Dimsoski has over 20 years of experience in commercial product development and leadership in…

 VIEW MORE

Stacey Shultz-Cherry

Ph.D.; Scientific Adviser

Stacey Schultz-Cherry is a Full Member (Professor) in the Department of Infectious Diseases at…

 VIEW MORE

Mirjana Stankovic

Ph.D.; Chief Operating Officer COO

Dr Stankovic is Senior Expert of Intellectual Property for the World Bank since 2016….

 VIEW MORE

Kiril Trpkov

Ph.D.; Chief Clinical Officer CCO

Dr. Kiril Trpkov is a Professor of Pathology at the University of Calgary, Alberta,…

 VIEW MORE

Greg North

J.D.; C.P.A.; Chief Financial Officer CFO

Greg is an accomplished tax and consulting advisor of publicly traded companies. With more…

 VIEW MORE

Gregory Miller

Ph.D.; Scientific Adviser

Dr. Miller is experienced Organic Chemist with considerable experience in oligo production and development…

 VIEW MORE

Bratislav Stankovic

Ph.D.; J.D.; Scientific Adviser

Seasoned international intellectual property attorney, scientist, and executive with 30+ years of rich professional…

 VIEW MORE
EMAIL ADDRESS

info@zeptobiosense.com

OFFICE ADDRESS

733 Industrial Rd San Carlos, CA 94070 USA